John R. Goldblum

John R. Goldblum

Auto-generated profile, based on publicly available information

John R. Goldblum

Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in Laboratory Investigation
Verified
Journal Article
Closed access
JWJoshua Weaver
Joshua Weaver
EDErinn Downs-Kelly
Erinn Downs-Kelly
JGJohn R Goldblum
John R Goldblum
STSondra Turner
Sondra Turner
SKSucheta Kulkarni
Sucheta Kulkarni
MSMarek Skacel
Marek Skacel

1 November 2002 in Gut
Verified
Journal Article
Open access
PDF file
AOA H Ormsby
A H Ormsby
RPR E Petras
R E Petras
WHW H Henricks
W H Henricks
TRT W Rice
T W Rice
LRL A Rybicki
L A Rybicki
JGJ R Goldblum
J R Goldblum
Background and aims: When to perform oesophagectomy for neoplastic progression in Barrett’s oesophagus is controversial. Some resect for high grade dysplasia whereas others defer treatment until intramucosal adenocarcinoma is diagnosed. Interobserver agreement for a diagnosis of high grade dysplasia or intramucosal adenocarcinoma remains unknown and may have therapeutic implications. Methods: Histological slides from 75 oesophagectomy specimens with high grade dysplasia or T 1 adenocarcinoma were blindly reviewed by two gastrointestinal pathologists and one general surgical pathologist, and classified as high grade dysplasia, intramucosal adenocarcinoma, or submucosal adenocarcinoma. A subsequent re-review of all 75 cases by the same observers following establishment of uniform histological criteria was undertaken. Interobserver agreement was determined by kappa statistics. Coefficients 0.80 were considered poor, fair, moderate, good, and very good agreement, respectively. Results: Interobserver agreement among all pathologists and between gastrointestinal pathologists when comparing high grade dysplasia with intramucosal adenocarcinoma was only fair (k=0.42; 0.56, respectively) and did not substantially improve on subsequent re-evaluation following establishment of uniform histological criteria (K=0.50; 0.61, respectively). Conclusions: When evaluating resection specimens and after implementation of uniform histological criteria, even experienced gastrointestinal pathologists frequently disagree on a diagnosis of high grade dysplasia versus intramucosal adenocarcinoma. Treatment strategies based on the histological distinction of high grade dysplasia from intramucosal adenocarcinoma using limited biopsy specimens should be re-evaluated.

1 August 2000 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
JGJohn R. Goldblum
John R. Goldblum
JRJohn D. Reith
John D. Reith
SWSharon W. Weiss
Sharon W. Weiss
There is a prevailing view that sarcomas arising in dermatofibrosarcoma protuberans (DFSP) have a higher risk of metastasis than ordinary DFSP, but these data are based on cases with variable and often suboptimal treatment. There has not been a large study of sarcomas arising in DFSP in which all cases were treated by wide local excision, thereby arguably altering outcome. Clinicopathologic features of 18 cases of sarcomas arising in DFSP treated by wide local excision and having follow up of at least 5 years were analyzed. An estimate of the proportion of sarcoma and DFSP was made. The number of mitotic figures and degree of CD34 immunoreactivity were assessed in each case. The cohort included 13 females and 5 males (age, 23-87 yrs; median, 47 yrs). The tumors involved the trunk (7), scalp (4), extremities (4), and inguinal region (3), and ranged from 1.5 to 7 cm (median, 4 cm). Sarcoma occurred de novo in 15 cases and in a recurrence in three. Sarcomas resembled fibrosarcoma (17) or malignant fibrous histiocytoma (1) and occupied between 20% and 80% of the tumor (median, 60%). Mitotic activity ranged from 2 to 16 per 10 high-power field (HPF; median 7 per 10 HPF) in the sarcomatous component and 0 to 3 per 10 HPF (median, 1 per 10 HPF) in the DFSP component. All tumors expressed CD34 in the DFSP component but only nine (50%) in the sarcomatous component. All patients were treated by wide local excision with negative margins; three additionally received radiation. Four patients (22%) developed recurrences, but none developed metastasis during the follow-up period of 62 months to 17 years (median, 81.5 mos). In contrast to earlier studies, we demonstrate that patients with sarcomas arising in DFSP do not have an increased risk of distant metastasis within a 5-year follow-up period, provided they are treated by wide local excision with negative margins. This probably reflects the fact that wide local excision results in eradication of local tumor, thereby eliminating the source for subsequent dissemination. However, we cannot completely exclude the possibility that tumors in which clear margins are achieved represent a less aggressive subset, as has been suggested for high-grade extremity sarcomas. Previous studies showing increased metastasis for sarcomas arising in DFSP should be re-evaluated to determine if, with treatment stratification, metastatic rate varies.

1 March 2001 in Laboratory Investigation
Verified
Journal Article
Closed access
KDKatharine A Downes
Katharine A Downes
JGJohn R Goldblum
John R Goldblum
EMElizabeth A Montgomery
Elizabeth A Montgomery
CFCyril Fisher
Cyril Fisher

1 April 2003 in Laboratory Investigation
Verified
Journal Article
Closed access
JGJohn R Goldblum
John R Goldblum

1 November 2001 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
JSJessica E. Sigel
Jessica E. Sigel
MSMarek Skacel
Marek Skacel
WBWilma F. Bergfeld
Wilma F. Bergfeld
NHNancy S. House
Nancy S. House
MRMichael S. Rabkin
Michael S. Rabkin
JGJohn R. Goldblum
John R. Goldblum